Solon Eiendom is headquartered in Oslo, Norway.
Solon Eiendom disclosed revenue of 1,498M NOK for 2020 and 1,585M NOK for 2019.
Solon Eiendom has 49 employees.
Solon Eiendom is a life science company.
Solon Eiendom was founded in 1993.
Olav Vs gate 5,
Oslo,
0116
Norway,
+47 23 01 09 60
www.soloneiendom.no
Solon Eiendom is a developer of vaccines for human immunodeficiency virus, Hepatitis C and Influenza. Solon Eiendom was founded in 1993 and is based in Oslo, Norway.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.0/yr) | # | 1 | - | - | - | - | - | 1 |
| vol | $121M | $121M | ||||||
| Sell (0.0/yr) | # | - | - | - | - | - | - | 0 |
| 1 | ||||||||
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
